Oral GLP-1s have moved from launch story to price-comparison story.
The UK private weight-loss market is now comparing injections, tablets, dose ladders, switching support and clinical checks in the same buying journey. That makes the cheapest visible price useful, but not enough on its own.
Provider pages are becoming more explicit about oral weight-loss medicines. Boots lists Wegovy tablets and Foundayo alongside Mounjaro, injectable Wegovy and orlistat, while Superdrug lists Wegovy Pill as in stock from £99 and publishes a Foundayo dose ladder from £99 to £199 at standard price.
The practical market signal is not just that tablets exist. It is that patients now need to compare tablet rules, dose escalation, switching advice, support and long-term price as carefully as they compare injections.
In this round-up
Oral GLP-1 pricing is now visible enough to compare
Boots Online Doctor currently shows Wegovy tablets from £99 and Foundayo tablets from £99 in its weight-loss treatment range. Superdrug Online Doctor also lists Wegovy Pill as in stock from £99.
That gives patients a clearer starting point than a waiting-list page, but the first visible price is only the start. Oral semaglutide has specific timing rules, strengths and a maintenance dose; orforglipron is a different medicine with a separate dose ladder.
Use the listed starter price as a prompt to compare the whole treatment route: dose increases, maintenance cost, support, side-effect advice, delivery and whether the provider confirms suitability before payment.
Foundayo is now a live comparison point on big pharmacy pages
Superdrug's Foundayo page says it is available in the UK through Superdrug Online Doctor and lists six dose prices, from £99 for 0.8mg to £199 for 17.2mg at standard price. Boots also lists Foundayo tablets from £99 in its weight-loss treatment range, while its page still asks users to confirm dose availability in the treatment flow.
For patients comparing services, that creates a useful but slightly messy market. A provider can advertise a treatment range while stock, dose availability, repeat ordering and NHS access remain separate questions.
Do not compare Foundayo only against Wegovy Pill on the starter dose. Ask which dose is being prescribed, what the likely next doses cost and what support is included if side effects or supply issues appear.
Switching from injections to tablets is becoming part of the sales journey
Boots has published switching guidance for people considering Wegovy or Mounjaro injections versus Wegovy or Foundayo tablets. That is a useful sign: as choices expand, patients need more than a price table.
Switching is still a clinical decision. Current dose, side effects, weight-loss response, medical history and preferences can all change what is appropriate. A good provider should explain that process before making a tablet sound like a simple upgrade.
| Question | Why it matters | Good provider answer |
|---|---|---|
| Can I switch? | Your current dose and side effects affect suitability. | Clinician review before changing treatment. |
| Which dose? | Starter and maintenance prices can be very different. | Clear dose ladder and follow-up plan. |
| What rules apply? | Tablet medicines can have different timing instructions. | Plain instructions before dispensing. |
| What if it does not suit me? | Side effects or poor response may need review. | Accessible support and safe stop/switch advice. |
The safety story has not changed: regulated routes matter
- Regulation: check the pharmacy and prescriber details before buying prescription-only medicines.
- Evidence checks: expect questions about BMI, medical history, medicines and contraindications.
- Transparent pricing: compare the monthly cost at likely later doses, not only the cheapest starter price.
- Support: look for side-effect guidance, messaging routes, follow-up reviews and delivery information.
Medical disclaimer
This article is for general information only and is not medical advice. Prescription medicines should only be used after assessment by a qualified healthcare professional.
